Laura Hayman to Risk Assessment
This is a "connection" page, showing publications Laura Hayman has written about Risk Assessment.
Connection Strength
0.924
-
Kariuki JK, Stuart-Shor EM, Leveille SG, Gona P, Cromwell J, Hayman LL. Validation of the nonlaboratory-based Framingham cardiovascular disease risk assessment algorithm in the Atherosclerosis Risk in Communities dataset. J Cardiovasc Med (Hagerstown). 2017 Dec; 18(12):936-945.
Score: 0.356
-
Muchira JM, Heelan-Fancher L, Hayman LL. Maternal Cardiovascular Health and Adverse Childbirth Outcomes in the United States: Analysis of the Pregnancy Risk Assessment Monitoring System. J Cardiovasc Nurs. 2021 Jul-Aug 01; 36(4):E51-E59.
Score: 0.114
-
Muchira JM, Gona PN, Mogos MF, Stuart-Shor E, Leveille SG, Piano MR, Hayman LL. Temporal Trends and Familial Clustering of Ideal Cardiovascular Health in Parents and Offspring Over the Life Course: An Investigation Using The Framingham Heart Study. J Am Heart Assoc. 2020 06 16; 9(12):e016292.
Score: 0.106
-
Worel JN, Hayman LL. A missed opportunity? Recognizing pregnancy-associated cardiovascular risk factors. J Cardiovasc Nurs. 2014 Sep-Oct; 29(5):381-3.
Score: 0.071
-
Dennison Himmelfarb CR, Commodore-Mensah Y, Hayman LL. New cardiovascular prevention guidelines offer a new approach and effective strategies. J Cardiovasc Nurs. 2014 Mar-Apr; 29(2):102-4.
Score: 0.069
-
Kariuki JK, Stuart-Shor EM, Leveille SG, Hayman LL. Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms. BMC Cardiovasc Disord. 2013 Dec 28; 13:123.
Score: 0.068
-
Hayman LL, Helden L, Chyun DA, Braun LT. A life course approach to cardiovascular disease prevention. Eur J Cardiovasc Nurs. 2011 Jul; 10 Suppl 2:S20-31.
Score: 0.057
-
Vadiveloo M, Lichtenstein AH, Anderson C, Aspry K, Foraker R, Griggs S, Hayman LL, Johnston E, Stone NJ, Thorndike AN. Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e000094.
Score: 0.027
-
Suglia SF, Koenen KC, Boynton-Jarrett R, Chan PS, Clark CJ, Danese A, Faith MS, Goldstein BI, Hayman LL, Isasi CR, Pratt CA, Slopen N, Sumner JA, Turer A, Turer CB, Zachariah JP. Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association. Circulation. 2018 01 30; 137(5):e15-e28.
Score: 0.022
-
Kariuki JK, Gona P, Leveille SG, Stuart-Shor EM, Hayman LL, Cromwell J. Cost-effectiveness of the non-laboratory based Framingham algorithm in primary prevention of cardiovascular disease: A simulated analysis of a cohort of African American adults. Prev Med. 2018 06; 111:415-422.
Score: 0.022
-
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009 Nov; 54(5):919-50.
Score: 0.013